Crossmark

Identification of (2<i>R</i>,3<i>R</i>)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach

Crossref DOI link: https://doi.org/10.1039/d1ra01603b

Published Online: 2021

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Selvaraj, Jubie

Sundar P, Shyam

Rajan, Logesh

Selvaraj, Divakar

Palanisamy, Dhanabal

Namboori PK, Krishnan

Mohankumar, Suresh Kumar https://orcid.org/0000-0001-8862-2979
License Information

Version of Record valid from 2021-04-07
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Krishnan Namboori PK (ResearcherID)

: Suresh Kumar Mohankumar (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 28 February 2021; Accepted 25 March 2021; Version of Record published 7 April 2021

Document is current

Any future updates will be listed below